Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells

Biochemical Pharmacology

Volumn 52, Issue 11, 1996, Pages 1703-1709

  De Mello, Maria A R ^a,c   Flodström, Malin ^a   Eizirik Decio L , Decio L ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

ebselen; hydrogen peroxide; insulin dependent diabetes mellitus; interleukin ; nitric oxide; pancreatic islets

Indexed keywords

ALLOXAN; CYTOKINE; EBSELEN; GLUCOSE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; REACTIVE OXYGEN METABOLITE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME INDUCTION; GLUCOSE OXIDATION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; MALE; MEDIATOR; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECOND MESSENGER;

ALLOXAN; ANIMALS; ANTIOXIDANTS; AZOLES; CYTOKINES; HUMANS; HYDROGEN PEROXIDE; INSULIN; INSULINOMA; INTERLEUKIN-1; ISLETS OF LANGERHANS; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; ORGANOSELENIUM COMPOUNDS; PANCREATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030582831     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00520-5     Document Type: Article

References (50)

1. 1. Wendel A, Fausel M, Safayhi H, Tiegs G and Otter R, A novel seleno-organic compound - II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 33: 3241-3245, 1984.
2. 2. Sies H, Ebselen: A glutathione peroxidase mimic. Method Enzymol 234: 476-482, 1994.
3. 3. Hattori R, Inoue R, Sase K, Eizama H, Kosuga K, Ayoama T, Masayasu H, Kawai C, Sasayama S and Yui Y, Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur J Pharmacol 267: R1-R2, 1994.
4. 4. Schewe T, Molecular actions of ebselen - An antiinflammatory antioxidant. Gen Pharmacol 26: 1153-1169, 1995.
5. 5. Bendtzen K, Immune hormones (cytokines): Pathogenic role in autoimmune arthritis and endocrine diseases. Autoimmunity 2: 177-189, 1989.
6. 6. Mandrup-Poulsen T, Helqvist TS, Wogensen LD, Molvig J, Pociot F, Johanennsen J and Nerup J, Cytokines and free radicals as effector molecules in the destruction of pancreatic β-cells. Curr Topics Microbiol Immunol 164: 169-193, 1990.
7. 7. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M and Welsh N, Biochemical and molecular actions of IL-1 on pancreatic β-cells. Autoimmunity 10: 241-253, 1991.
8. 8. Southern C, Schulster D and Green I C, Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine dependent nitric oxide generation mechanism. FEBS Lett 276: 42-44, 1990.
9. 9. Welsh N, Eizirik DL, Bendtzen K and Sandler S, Interleukin-1β induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 3167-3173, 1991.
10. 10. Corbett JA, Lancaster JR Jr, Sweetland MA and McDaniel ML, Interleukin-1β induced formation of EPR detectable iron nytrosil complexes in islets of Langerhans. Role of nitric oxide in IL-1β induced inhibition of insulin secretion. J Biol Chem 266: 21351-21354, 1991.
11. 11. Eizirik DL, Interleukin-1-induced impairment in pancreatic islets oxidative metabolism is potentiated by tumor-necrosis factor. Acta Endocrinol 119: 321-325, 1988.
12. 12. Eizirik DL, Sandler S, Holberg A, Bendtzen K, Sener A and Malaisse WJ, Differential sensivity to β-cell secretagogues in rat islets exposed to human interleukin-1β. Endocrinology 125: 752-759, 1989.
13. 13. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Niemann A, Geller DA, Pipeleers DG, Bendtzen K and Hellerström C, Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93: 1968-1974, 1994.
14. 14. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr and McDaniel ML, Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90: 1731-1735, 1993.
15. 15. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Schultz R, Lackey JRT, Warnock GL and Rajotte RV, Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79: 1058-1062, 1994.
16. 16. Rabinovitch A, Roles of cytokines in IDDM pathogenesis and islet β-cell dysfunction. Diabetes Rev 1: 215-240, 1993.
17. 17. Hughes JH, Colca JR, Easom RA, Turk J and McDaniel ML, Interleukin-1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest 86: 856-863, 1990.
18. 18. Eizirik DL, Bendtzen K and Sandler S, Short exposure of rat pancreatic islets to interleukin-1β induces a substantial but reversible impairment in β-cell function. This effect is influenced by protease activation, gene transcription and protein synthesis. Endocrinology 128: 1611-1616, 1991.
19. 19. Eizirik DL, Cagliero E, Björklund A and Welsh N, Interleukin-1β induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages. FEBS Lett 3: 249-252, 1992.
20. 20. Saldeen J and Welsh W, Interleukin-1β induced activation of NF-κB in insulin-producing RINm5F cells is prevented by the protease inhibitor Nα-p-tosyl-L-lysine chloromethylketone. Biochem Biophys Res Commun 203: 149-155, 1994.
21. 21. Bedoya FJ, Flodström M and Eizirik DL, Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin-producing cells. Biochem Biophys Res Commun 210: 816-822, 1995.
22. 22. Kwon G, Corbett JA, Rodi CP, Sullivan P and McDaniel ML, Interleukin-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: Evidence for the involvement of nuclear factor κB in the signalling mechanism. Endocrinology 138: 4790-4795, 1995.
23. 23. Thanos D and Maniatis T, NF-κB: A lesson in family values. Cell 80: 529-532, 1995.
24. 24. Schmidt KN, Amstad P, Cerutti P and Baeuerle PA, The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB, Chem Biol 2: 13-22, 1995.
25. 25. Schulze-Osthoff K, Loss M and Baeuerle PA, Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol 50: 735-741, 1995.
26. 26. Schreck R, Meir B, Männel D, Dröge W and Baeuerle PA, Dithiocarbamates as potent, inhibitors of nuclear factor κB activation in intact cells. J Exp Biol Med 175: 1181-1194, 1992.
27. 27. Xie Q-W, Kashiwabara Y and Nathan C, Role of transcription factor NPκB/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994.
28. 28. Eberhardt W, Kuns D and Pfeilschifter J, Pytrolidine dithiocarbamate differentially affects interleukin 1 beta and cAMP-induced nitric oxide synthase expression in rat mesangial cells. Biochem Biophys Res Commun 200: 163-170, 1994.
29. 29. Flodström M, Niemann A, Bedoya FJ, Morris SM and Eizirik DL, Expression of citrulline-nitric oxide cycle in rodent and human pancreatic, β-cells: Induction of argininosuccinate synthase by cytokines. Endocrinology 136: 3200-3206, 1995.
30. 30. Brennan P and O'Neil LA, Effects of oxidants on nuclear κB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260: 167-175, 1995.
31. 31. Andersen A, Isolated mouse pancreatic islets in culture: Effects of serum and different culture medium on insulin production of the islets. Diabetologia 14: 397-404, 1978.
32. 32. Eizirik DL and Sandler S, Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. Pharmacol Toxicol 63: 396-399, 1988.
33. 33. Eizirik DL, Korbutt GS and Hellerström C, Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest 90: 1263-1268, 1992.
34. 34. Sandier S, Bendtzen K, Eizirik DL, Sjöholm A, and Welsh N, Decreased cell replication and polyamide content in insulin-producing cells after exposure to human IL-1β. Immunol Lett 22: 267-272, 1989.
35. 35. Eizirik DL, Björklund A and Welsh N, Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett 317: 62-66, 1993.
36. 36. Niemann A, Björklund A and Eizirik DL, Studies on the molecular regulation of the inducible form of the nitric oxide synthase (iNOS) in insulin-producing cells. Mol Cell Endocrinol 106: 151-155, 1994.
37. 37. Heding LG, Determination of total serum insulin (IRI) in insulin treated patients. Diabetologia 8: 260-266, 1972.
38. 38. Eizirik DL, Welsh M, Strandell E, Welsh N and Sandler S, Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127: 2290-2297, 1990.
39. 39. Hinegardner RT, An improved fluorimetric assay for DNA. Anal Biochem 39: 197-201, 1971.
40. 40. Lyons RC, Orloff GJ and Cunningham JM, Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370-6374, 1992.
41. 41. Katz RA, Mitsialis SA and Guntoka RV, Studies on the methylation of avian sarcoma parvoviruses in permissive and nonpermissive cells. J Gen Virol 64: 429-435, 1983.
42. 42. Siebenlist U, Franzoso G and Brown K, Structure, regulation and function of NF-κB. Annu Rev Cell Biol 110: 405-455, 1994.
43. 43. Bradford MM, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
44. 44. Wallenstein S, Zucker CL and Fleiss JL, Some statistical methods useful in circulation research, Cir Res 47: 1-9, 1980.
45. 45. Malaisse WJ, Alloxan toxicity to the β-cell. A new hypothesis. Biochem Pharmacol 31: 3527-3534, 1982.
46. 46. Eizirik DL and Kisby GE, Cycad toxin induced damage of rodent and human pancreatic islets. Biochem Pharmacol 50: 355-65, 1995.
47. 47. Flodström M, Welsh N and Eizirik DL, Cytokines activate the nuclear factor κB (NF-κB) and induce nitric oxide production in human pancreatic islets. FEBS Lett 385: 4-8, 1996.
48. 48. O'Neil LAJ, Towards understanding of the signal transduction pathway for interleukin-1. Biochem Biophys Acta 1266: 31-44, 1995.
49. 49. Eizirik DL, Flodström M, Karlsen AE and Welsh N, The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39: 875-890, 1996.
50. 50. Hecker M, Preiß C, Schini-Kerth VB and Busse R, Antioxidants differentially effect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 380: 224-228, 1996.